Healthcare Realty Trust rporated(HR) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - In Q4 2025, normalized FFO per share was $0.40, with full-year normalized FFO per share reaching $1.61, exceeding the midpoint of original guidance by $0.03 [10][23] - Same-store cash NOI growth for 2025 was 4.8%, surpassing the midpoint of original guidance by 140 basis points [11][23] - The company achieved a quarterly dividend payout ratio of 75% with FAD per share at $0.32 [23] Business Line Data and Key Metrics Changes - The company executed approximately 5.8 million sq ft of leases in 2025, including 1.6 million sq ft of new leases [15][11] - Tenant retention improved to 82% for the year, with same-store absorption translating to over 100 basis points of occupancy gain [15][16] - Cash leasing spreads improved by 3.7% in Q4, contributing to overall positive lease economics [23] Market Data and Key Metrics Changes - The outpatient medical transaction volume increased significantly in 2025, driven by rising patient and tenant demand amid a lack of new supply [11][12] - Demand in the top 100 MSAs continues to outstrip supply, with completions as a percentage of inventory remaining near all-time lows [16] Company Strategy and Development Direction - The company aims to become a leader in the outpatient medical sector, focusing on enhancing its asset management platform and improving alignment between asset management and leasing [5][7] - A three-year strategic plan was published in July, with key steps to overhaul the organization, including achieving $10 million in G&A savings and completing an ambitious asset disposition plan [6][8] - The company plans to prioritize redevelopment projects within its existing portfolio, targeting attractive yields on cost of approximately 10% [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's financial flexibility and balance sheet capacity for capital allocation, with a stable outlook from credit rating agencies [9][24] - The company anticipates same-store cash NOI growth of 3.5%-4.5% for 2026, with a focus on maintaining financial discipline around leasing and improving tenant satisfaction [25][31] - Management acknowledged the challenges posed by the current cost of capital and discount to intrinsic asset value, emphasizing a disciplined capital allocation approach [11][12] Other Important Information - The company has reduced net debt to EBITDA to 5.4x, down from 6.4x at the beginning of the year, ahead of target [24] - The dividend has been right-sized to be appropriate and well-covered, currently offering a nearly 6% yield to shareholders [10] Q&A Session Summary Question: Same-store NOI guidance for 2026 - Management explained that the 3.5%-4.5% guidance reflects a deceleration from 2025's strong performance, with expectations for continued positive absorption and retention trends [30][31] Question: CapEx relative to FAD expectations for 2026 - Management indicated that if FFO remains flat, FAD is also expected to be flat, with maintenance capital numbers provided in guidance to assist modeling [36][38] Question: Absorption potential and redevelopment project timing - Management confirmed that the absorption figures discussed were specific to the same-store portfolio, with redevelopment expected to significantly contribute to total portfolio occupancy in the coming years [40][41] Question: Acquisition potential and profile - Management stated that any acquisitions would be pursued only if they meet the company's yield criteria, emphasizing a disciplined approach to capital allocation [43][46] Question: Disposition strategy moving forward - Management outlined that $175 million of sales are embedded in guidance for the year, with a focus on maximizing shareholder value through potential sales of non-core assets [49][50]